Synaptogenix Inc (SNPX)

[runncoach]

All big pharma failures have rightly made folks skeptical of AD cures. The plaque research in mice has not transferred over into humans and it makes it difficult for folks to put lots of money into a stock that is up 250% this year, knowing the huge risk. No matter what the science has shown for our MOA, its risky. If big pharma fails a drug they lose 10% of their share price. If we fail, we could lose at least half depending on the degree of the drug's effectiveness or lack thereof. If we are successful, we'll be the 2017 stock of the year and everyone will jump on the bandwagon. Big pharma will be all over us. That's how it works. They are in wait and see mode and with a marketcap of only 150 million they can afford to wait and see at this point. This one isn't for that faint of heart. Let's hope we are some of the few who had the foresight/luck and get the big payoff.